Conserved mechanism, one rate-limiting hub. The key conformance target is the central_effector node "MAPK Signaling and AP-1/NF-kB Transcriptional Activation": every route from a UV/oxidative insult to matrix destruction funnels through MAP-kinase-driven AP-1 (and NF-kB) transcriptional activation. Conforming entries substitute the tissue- and stimulus-specific detail while keeping this spine: the UV waveband and dose (UVB vs UVA vs solar-simulated), the dominant reactive species, the specific MMPs induced (MMP-1 collagenase, MMP-3 stromelysin, MMP-9 gelatinase), and the inflammatory mediators (IL-1, IL-6, CXCL8/IL-8, PTGS2/COX-2). Not modeled here and left to the conforming entry or a sibling module: UV mutagenesis and photocarcinogenesis (a distinct DNA-damage/oncogenesis output), melanogenesis and dyspigmentation, and the intrinsic (chronological) aging arm, which converges on the same AP-1/MMP effector but is driven by senescence and inflammaging rather than UV (see the cellular_senescence and inflammaging modules). Chemistry (ROS, retinoids) is described in prose per module convention; a treatment therapeutic_agent carries the CHEBI id. Not an Xogenesis module: the terminal output is destruction and disorganization of a normal matrix, not formation of a discrete pathological structure (actinic/solar elastosis, an accumulation of abnormal elastotic material, is the closest structural correlate and is described in prose at the consequence node rather than anchored as Xogenesis).
UVB Irradiation and Photo-oxidative Injury
trigger
Ultraviolet irradiation (chiefly UVB) absorbed by skin chromophores inflicts direct DNA photodamage and generates reactive oxygen species, and acts as a broad ligand-independent activator of keratinocyte and dermal-cell growth-factor and cytokine receptors. This photo-oxidative injury is the initiating insult of extrinsic skin aging.
Downstream
-
MAPK Signaling and AP-1/NF-kB Transcriptional Activation
Photo-oxidative injury and receptor activation transduce into MAP-kinase signaling that activates the AP-1 and NF-kB transcription factors.
Show evidence (2 references)
"UV irradiation acts as a broad activator of cell surface growth factor and cytokine receptors."
Establishes UV as a broad ligand-independent activator of keratinocyte and dermal-cell receptors, the initiating injury of this node.
"the skin is a major target for toxic insult by a broad spectrum of physical (i.e. UV radiation) and chemical (xenobiotic) agents"
A dermatology review grounding UV as an oxidative and toxic insult to skin, the photo-oxidative dimension of this node.
MAPK Signaling and AP-1/NF-kB Transcriptional Activation
central effector
UV-activated cell-surface receptors and reactive oxygen species drive MAP-kinase cascades (p38, ERK, JNK) that converge on the nucleus to induce c-Jun, which heterodimerizes with c-Fos to form the AP-1 transcription factor, and to activate NF-kB. This transcriptional hub is the disorder-agnostic, rate-limiting step that couples the UV/oxidative insult to matrix-degrading and inflammatory gene expression.
Downstream
-
MMP Upregulation and Inflammatory Mediator Induction
AP-1 and NF-kB induce transcription of matrix metalloproteinases and pro-inflammatory mediators.
Show evidence (2 references)
"ultraviolet irradiation activates growth factor and cytokine receptors on keratinocytes and dermal cells, resulting in downstream signal transduction through activation of MAP kinase pathways"
Describes UV-driven ligand-independent receptor activation feeding MAP-kinase pathways, the upstream half of this hub.
"These signaling pathways converge in the nucleus of cells to induce c-Jun, which heterodimerizes with constitutively expressed c-Fos to form activated complexes of the transcription factor AP-1."
Establishes the AP-1 (c-Jun/c-Fos) transcription factor as the convergent output of UV-activated MAP-kinase signaling.
Dermal ECM (Collagen and Elastin) Degradation
effector
MMP-mediated proteolysis, together with reduced procollagen synthesis (compounded by UV inhibition of TGF-beta signaling), fragments and depletes the dermal collagen and elastin extracellular matrix. Repeated cycles of degradation and imperfect repair accumulate as disorganized matrix, including the abnormal elastotic material of solar (actinic) elastosis.
Downstream
-
Photoaging
Cumulative dermal matrix loss and disorganization manifests as clinical photoaging.
Show evidence (2 references)
"skin aging is associated with increased AP-1 activity, increased MMP expression, impaired TGF-beta signaling, enhanced collagen degradation, and decreased collagen synthesis"
Ties AP-1/MMP activation and impaired TGF-beta signaling to enhanced collagen degradation with decreased synthesis, the net matrix loss modeled here.
"The dermal collagenous extracellular matrix, which comprises the bulk of skin and confers strength and resiliency, undergoes gradual fragmentation, which deleteriously impacts skin mechanical properties and dermal cell functions."
Documents fragmentation of the dermal collagenous ECM and its functional consequences, the structural core of photoaging.
Photoaging
consequence
The cumulative clinical outcome: wrinkling, laxity, roughness, dyspigmentation, and solar elastosis of chronically sun-exposed skin. Photoaging is a cumulative process whose severity tracks lifetime UV dose and skin pigmentation, distinct from the passage-of-time-dependent intrinsic aging with which it shares the downstream AP-1/MMP effector.
Show evidence (2 references)
"This sun-induced skin aging (photoaging), like chronological aging, is a cumulative process."
Defines photoaging as the cumulative sun-induced skin-aging endpoint of this pathway.
"leading to accumulation of solar scarring, and ultimately visible photoaging"
Frames repeated dermal degradation and imperfect repair as accumulating into visible photoaging.
Topical retinoid (tretinoin / all-trans retinoic acid)
Platform:
Small molecule
All-trans retinoic acid opposes the UV response upstream of matrix destruction by inhibiting UV-induced c-Jun and thereby AP-1-driven MMP induction, the peer-reviewed drug-target pattern for this module. Acts on the central AP-1/NF-kB node rather than the UV insult itself.
Evidence: 1
Topical sunscreen (photoprotection)
Platform:
Other
Topical broad-spectrum sunscreen blocks UV from reaching skin chromophores, acting at the trigger node to prevent the initiating photo-oxidative injury. The primary evidenced-here demonstration is in the ex vivo human skin model below; the citation is a preprint.
Evidence: 1